Table 2. Optimal cutoff point: Total number of lymph node metastasis vs. survival.
Training (n = 497) | Testing (n = 300) | |||||||
---|---|---|---|---|---|---|---|---|
Methods | Cutoff point | Recurrence | Death | |||||
Recurrence | Death | NMLN* | Stage | Histology | NMLN* | |||
Log-rank test | 5 | 5 | HR* | 6.653 | 163.2 | 1 | 0.117 | 5.781 |
2 | 0.283 | |||||||
Likelihood ratio test | 5 | 5 | p | 0.007 | 0.0004 | 1 | 0.004 | 0.035 |
2 | 0.281 |
* NMLN: number of metastatic lymph nodes, HR: hazard ratio. HR1 for histology was the hazard ratio of squamous cell carcinoma vs. other types, and HR2, adenocarcinoma vs. other types.